<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02736396</url>
  </required_header>
  <id_info>
    <org_study_id>P0867</org_study_id>
    <nct_id>NCT02736396</nct_id>
  </id_info>
  <brief_title>Southend Imaging Study</brief_title>
  <acronym>SIS</acronym>
  <official_title>Southend Imaging Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mid and South Essex NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Anglia Ruskin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mid and South Essex NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to correlate global cognition and episodic memory performance to&#xD;
      resting state fMRI functional connectivity. This is a non-treatment, prospective, natural&#xD;
      history data collection study in a cross-sectional cohort of patients with cognitive&#xD;
      impairment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At present, Magnetic Resonance Imaging (MRI) is widely used along with other tests to help&#xD;
      diagnose dementia, however diagnosis still remains challenging. There is currently a focus on&#xD;
      the usefulness of resting state functionalMRI (RS fMRI) as a way of establishing differences&#xD;
      in functional connectivity between healthy subjects and those with various neurodegenerative&#xD;
      disorders. Although the potential for RS fMRI to be used as a biomarker for neurological&#xD;
      diseases looks promising, further research is needed, especially regarding validation of&#xD;
      normal values and seed-based functional connectivity. Further research into this area will&#xD;
      help to improve the ability to appropriately classify new subjects and ultimately allow use&#xD;
      of RS functional connectivity as a biomarker. This is a nontreatment, prospective, natural&#xD;
      history data collection that aims to analyse functional connectivity in a cohort of patients&#xD;
      with suspected cognitive impairment. Correlation of global cognition and episodic memory&#xD;
      performance to resting state fMRI functional connectivity will be evaluated. Patient&#xD;
      population will include patients over the age of 18 with cognitive impairment and age and&#xD;
      gender matched controls. Eligible patients will have to complete neuropsychological and&#xD;
      clinical assessments and complete an fMRI scan prior to enrolment.Study duration is estimated&#xD;
      at 4 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2016</start_date>
  <completion_date type="Actual">September 2020</completion_date>
  <primary_completion_date type="Actual">November 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the functional connectivity in the Default Mode Network .</measure>
    <time_frame>4 years</time_frame>
    <description>Evaluating the correlation of the Default Mode Network functional connectivity to types of dementia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of cognitive performance to functional connectivity.</measure>
    <time_frame>4 years</time_frame>
    <description>To evaluate the correlation between individual measures of functional connectivity and global and episodic cognitive performance as measured by neuropsychological tests.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">37</enrollment>
  <condition>Cognition Disorders</condition>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Medical History, Neuropsychological tests, clinical assessments, fMRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cognitive impairment</arm_group_label>
    <description>Medical History, Neuropsychological tests, clinical assessments, fMRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>Functional MRI scan to be performed</description>
    <arm_group_label>Cognitive impairment</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological tests</intervention_name>
    <description>Cognitive assessments will be performed, including Mini Mental State Examination, Rey Auditory Verbal Learning Test, Stroop, Visual Short Term Memory Assessment.</description>
    <arm_group_label>Cognitive impairment</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspected cognitive impairment, mild cognitive impairment, autosomal dominant&#xD;
        Alzheimer's disease, late onset Alzheimer's disease, Vascular dementia, Parkinson's&#xD;
        dementia and age and gender matched controls.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Cognitive impairment&#xD;
&#xD;
          -  Age from 18 to 100 years&#xD;
&#xD;
          -  On stable medication for 1 month before the screening visitÍ¾ on or off cholinesterase&#xD;
             inhibitors&#xD;
&#xD;
          -  Fluency in English and adequate premorbid intellectual functioning&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any contraindication to MRI scanning&#xD;
&#xD;
          -  Clinically significant psychiatric disorder (e.g. depression)&#xD;
&#xD;
          -  Current clinically significant illness that could confound the results of the study&#xD;
&#xD;
          -  History of alcohol or drug dependence or abuse&#xD;
&#xD;
          -  Current use of anticonvulsant or narcotic medications.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paula A Harman, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southend University Hospital NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southend Hospital</name>
      <address>
        <city>Westcliff on Sea</city>
        <state>Essex</state>
        <zip>SS0 0RY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>March 8, 2016</study_first_submitted>
  <study_first_submitted_qc>April 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2016</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

